UK Drug Trials for Systemic Mastocytosis Opening/Expanding

Trials for two new medications for people with systemic mastocytosis are recruiting patients in the UK.  

Blueprint Medicines is expanding its Phase I trial of Avapritinib in adults with Advanced Systemic Mastocytosis (Aggressive SM, SM with an Associated Haematologic Disease and Mast Cell Leukemia) and is launching a new Phase I trial of Avapritinib in people with Indolent or Smouldering Systemic Mastocytosis.   For more information you can read about the trials here or by emailing the company.

Deciphera Pharmaceuticals are recruiting for a Phase I trial of their new medication, DCC-2618, for adults with Advanced Systemic Mastocytosis (Aggressive SM, SM with an Associated Haematologic Disease and Mast Cell Leukemia).  For more information you can read about the trials here or by emailing the company.